FDA Inspection
Nuvasive PR, Inc.Nuvasive PR, Inc. – FDA Inspection, Feb 11, 2014
Record Details
This FDA Inspection record concerns Nuvasive PR, Inc., with an inspection on February 11, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Nuvasive PR, Inc.
- Inspection Date
- February 11, 2014
- Product Type
- Biologics
View Company Profile
ID · 0222c183-1ca1-43de-9e5d-f0ac07c23fee
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 865516
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.270(a)Records incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nuvasive PR, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 18, 2024 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| December 9, 2019 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 31, 2017 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 10, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 1, 2014 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Nuvasive PR, Inc.
- FDA Inspection 1228326 - 2024-01-18
- FDA Inspection 1122594 - 2019-12-09
- FDA Inspection 1014500 - 2017-05-31
- FDA Inspection 969787 - 2016-02-10
- FDA Inspection 887388 - 2014-04-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.